Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsReceivables RefundsShares Repurchased
Ratios

Takeda Pharmaceutical (TKPHF) Short-Term Debt issuances (2018 - 2020)

Historic Short-Term Debt issuances for Takeda Pharmaceutical (TKPHF) over the last 3 years, with Q1 2020 value amounting to -$238.6 million.

  • Takeda Pharmaceutical's Short-Term Debt issuances fell 10714.21% to -$238.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$3.2 billion, marking a year-over-year decrease of 19510.04%. This contributed to the annual value of -$3.2 billion for FY2020, which is 19685.08% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Short-Term Debt issuances of -$238.6 million as of Q1 2020, which was down 10714.21% from $1.3 billion recorded in Q4 2019.
  • In the past 5 years, Takeda Pharmaceutical's Short-Term Debt issuances ranged from a high of $3.3 billion in Q1 2019 and a low of -$4.5 billion during Q2 2019
  • For the 3-year period, Takeda Pharmaceutical's Short-Term Debt issuances averaged around $20.4 million, with its median value being -$991630.9 (2018).
  • The largest annual percentage gain for Takeda Pharmaceutical's Short-Term Debt issuances in the last 5 years was 9889662.02% (2019), contrasted with its biggest fall of 63568084.08% (2019).
  • Quarter analysis of 3 years shows Takeda Pharmaceutical's Short-Term Debt issuances stood at -$1.3 million in 2018, then soared by 98896.62% to $1.3 billion in 2019, then tumbled by 119.05% to -$238.6 million in 2020.
  • Its last three reported values are -$238.6 million in Q1 2020, $1.3 billion for Q4 2019, and $361.5 million during Q3 2019.